Status: On trackOBS-PMR-001
Sponsor viewShared with Veridian Pharma
Veridian Pharma
OBS-PMR-001 · Long-term safety surveillance of verexitide in T2DM
ObservationalDatabase lockPost-marketing / Real-worldOn track
Executive summary
PASS-style 5-year real-world safety registry, contracted by EMA commitment. Database lock executed on schedule; CSR drafting underway.
Phase
Observational
Stage
Database lock
Health
On track
Milestone timeline
Showing completed, in-progress, and at-risk milestones. Planned future milestones are omitted from the sponsor view.
Sep 1, 2020forecast end Oct 18, 2026
- Complete
FPI
Sep 9, 2020
- Complete
25% enrolment
Jul 4, 2021
- Complete
50% enrolment
Feb 15, 2022
- Complete
75% enrolment
Oct 2, 2022
- Complete
LPI
Jun 22, 2023
- Complete
LPLV
Mar 28, 2026
- Complete
Database lock
May 15, 2026
- In progress
CSR draft
Aug 2, 2026
Signed deliverables
Updated live as deliverables are signed.
- Essential Documentsfiled and signed
- Audit Trailgreen
- CSR draftnot yet released to sponsor
Request an update
Ask for a status update, request a document, or submit a question. The study lead is notified and you’ll see the response in this portal.